Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab). (Q39933579)
Jump to navigation
Jump to search
scientific article published on October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab). |
scientific article published on October 2008 |
Statements
1 reference
Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab). (English)
1 reference
M Jules Mattes
1 reference
Robert M Sharkey
1 reference
Habibe Karacay
1 reference
Myron S Czuczman
1 reference
David M Goldenberg
1 reference
1 October 2008
1 reference
1 reference
14
1 reference
19
1 reference
6154-6160
1 reference
Identifiers
1 reference
1 reference